Swayam Prabha, MBA, PhD

My current efforts are focused on developing novel drug/gene delivery approaches to fulfill unmet therapeutic needs. My tenure in the pharmaceutical industry and involvement in the development of clinical formulations, several of which have been successfully approved by the FDA, have enabled a deeper understanding of what it takes to translate ideas and concepts from laboratory into a clinical drug product. I hope to utilize this knowledge to devise therapies that are highly effective and have fewer side effects for lung and ovarian cancers, both diseases with poor survival rates and in urgent need of novel therapeutic approaches.